Angidak spray 0.255mg / dose 88 doses


Angidak spray 0.255mg / dose 88 doses


SKU: 01177984844 Categories: , , Tags: ,


Active substance:
1 dose contains: 0.255 mg of benzydamine hydrochloride.
Ethanol 95% 13.89 mg glycerol 8.52 mg 0.17 mg methyl parahydroxybenzoate, 0.051 mg of mint flavor, sodium saccharinate 0.041 mg, 0.019 mg sodium bicarbonate, polysorbate 20 0.009 mg, 1 M sodium hydroxide solution or 0.5 M hydrochloric acid to pH 5.0-7.0 water for injection to 170 ml.
Clear, colorless or slightly yellowish liquid with a characteristic odor of mint.
Product form:
Spray for topical application dosage of 0.255 mg / dose.
By 88 doses (15 ml) or 176 doses (30 ml) into vials of high density polyethylene with the pump and with the pressure device with a folding cannula.
1 bottle together with instructions for use in a stack of cardboard.
Hypersensitivity to benzydamine or other components of the formulation; Children up to age 3 years.
Increased sensitivity to aspirin or other nonsteroidal anti-inflammatory drugs, bronchial asthma (including history).
0.255 mg / dose
Symptomatic therapy of pain of inflammatory diseases of the oral cavity and upper respiratory organs (different etiology): – gingivitis, glossitis, periodontitis, stomatitis (including after radiotherapy and chemotherapy); – pharyngitis, laryngitis, tonsillitis; – candidiasis of the oral mucosa (in combination therapy); – calculous inflammation of the salivary glands; – after surgery and trauma (tonsillectomy, mandible fractures); – after treatment and extraction.
In infectious and inflammatory diseases requiring systemic treatment, it is necessary to use the drug in a combination therapy.
Interaction with other drugs
Studies of interaction with other drugs has not been performed.
Currently, the cases of overdose have been reported.
Symptoms: The use of the preparation according to the instructions for use overdose unlikely. If accidentally ingested, the following symptoms medication: vomiting, abdominal cramps, anxiety, fear, hallucinations, seizures, ataxia, fever, tachycardia, respiratory depression.
Treatment: symptomatic; clear the stomach, causing vomiting or stomach wash, using a gastric tube (under medical supervision); provide medical supervision, maintenance therapy and the necessary hydration. The antidote is not known.
pharmachologic effect
Pharmacological group:
Nonsteroidal anti-inflammatory drug.
Benzydamine is a non-steroidal anti-inflammatory drug that belongs to a group of indazoles. Anti-inflammatory and local anesthetic effect, has an antiseptic effect against a broad spectrum of microorganisms, restores microcirculation. The mechanism of action of the drug associated with the stabilization of cell membranes and inhibition of prostaglandin synthesis. Benzydamine has a specific antibacterial and antimicrobial action due to the rapid penetration through the membrane of microorganisms with consequent damage to cell structures, disturbance of metabolic processes and cell lysosomes. It has an antifungal activity against Candida albicans. It causes structural modification of the cell wall of fungi and their metabolic chains thus prevents their reproduction, which was the basis for the use of benzydamine in inflammatory processes in the oral cavity, including infectious etiology.
When applied topically, the drug is well absorbed through mucous membranes and penetrate into the inflamed tissue is found in blood plasma in an amount insufficient to produce systemic effects. Excretion of the drug takes place mainly in the kidney as inactive metabolites or conjugation product.
Pregnancy and breast-feeding
It should not be used during pregnancy and lactation.
Conditions of supply of pharmacies
Without recipe.
side effects
Classification of the incidence of adverse events according to the World Health Organization (WHO):
Very often -> 1/10.
Often – from 1/100 to
Infrequently – by> 1/1000 to
Seldom – by> 1/10000 to
Very rarely –
The frequency is not known – can not be estimated from the available data.
In each group, undesirable effects are presented in order of decreasing seriousness.
Local reactions: rarely – dry mouth, burning sensation in the oral cavity; frequency is unknown – numbness in the oral cavity.
Allergic reactions: seldom – photosensitivity; rarely – hypersensitivity reactions, skin rash, itching; very rarely – angioedema, laryngospasm; frequency is unknown – anaphylactic reaction.
If any of these instructions side effects are compounded, or observed any other side effects not mentioned in the instructions, you should immediately inform your doctor.
special instructions
In applying the drug may develop hypersensitivity reactions. In this case, it is recommended to discontinue treatment and consult a doctor for the appointment of appropriate therapy.
In a limited number of patients the presence of ulcers in the throat and mouth may indicate the presence of more serious disease. If symptoms persist for more than 3 days, you should consult with your doctor.
Use of the drug is not recommended in patients with hypersensitivity to aspirin or other nonsteroidal antiinflammatory drugs.
The drug should be used with caution in patients with bronchial asthma in history due to the development opportunities they bronchospasm in patients receiving the drug.
The preparation contains parahydroxybenzoates, which can cause allergic reactions.
The preparation contains 13.2 mg of ethanol per dose (one injection).
The ethanol content in a single dose – for adults (including elderly patients) and children over 12 years – 52.8 – 105.6 mg; – for children from 6 to 12 years – 52.8 mg; – for children from 3 to 6 years of age – 13.2 mg of ethanol for every 4 kg body weight, but not more than 52.8 mg (maximum single dose).
The effect on the ability of control of vehicles and mechanisms
It does not affect the ability to drive vehicles and use machines.
Storage conditions
At a temperature of not higher than 25 C.
Keep out of the reach of children.
Dosing and Administration
Locally, the food. One dose (single injection) corresponds to 0.255 mg of benzydamine.
Adults (including elderly patients) and children over 12 years – 4-8 injections 2-6 times a day.
Children from 6 to 12 years – 4 injections 2-6 times a day.
Children from 3 to 6 years – 1 injection per 4 kg body weight, but not more than 4 injections (maximum single dose) 2-6 times a day.
The course of treatment Duration of treatment 7 days; If after 7 days of treatment there is no improvement, consult a doctor.
Directions for use: 1. Turn cannula (white tube) to “vertically to the bottle.” 2. Insert the cannula into his mouth and point to the inflamed place in the mouth and throat. 3. Click on the dosing pump on the top of the bottle as often as prescribed doses.
One click corresponds to a single dose. Hold your breath during the injection.
Note: Before the first use, press several times on the spray gun into the air.
Do not exceed the recommended dose. Prior to use, consult your doctor.
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg

Grotex Ltd.

There are no reviews yet.

Add your review